We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.87%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.66B
AUM Growth
-$665M
(-9.1%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-15.73%
Top 10 Holdings %
Top 10 Hldgs %
26.74%
Holding
1,056
New
179
Increased
184
Reduced
165
Closed
479
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$95M |
| 2 |
Elevance Health
ELV
|
+$42.9M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$37.7M |
| 4 |
Baxter International
BAX
|
+$37.1M |
| 5 |
AGN
Allergan plc
AGN
|
+$29.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$184M |
| 2 |
Perrigo
PRGO
|
+$168M |
| 3 |
Cigna
CI
|
+$109M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$90M |
| 5 |
AET
Aetna Inc
AET
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 51.29% |
| 2 | Financials | 8.13% |
| 3 | Energy | 5.44% |
| 4 | Industrials | 5.17% |
| 5 | Technology | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $342M | 5.14% |
1,095,685
+98,484
| +10% | +$29.3M |
|
2
Labcorp
LH
$25.5B
| $342M | 5.13% |
3,216,756
-297,334
| -8% | -$30.7M |
|
|
ENDP
3
DELISTED
Endo International plc
ENDP
| $317M | 4.76% |
5,172,598
-31,402
| -0.6% | -$1.91M |
|
4
Pacira BioSciences
PCRX
$1.04B
| $176M | 2.64% |
2,291,010
-660,374
| -22% | -$37.4M |
|
5
Neurocrine Biosciences
NBIX
$18.2B
| $125M | 1.87% |
2,201,850
+2,345
| +0.1% | +$119K |
|
|
6
Brookdale Senior Living
BKD
$3.57B
| $111M | 1.66% |
5,997,550
+4,412,499
| +278% | +$95M |
|
|
7
Perrigo
PRGO
$1.45B
| $103M | 1.55% |
714,569
-1,089,487
| -60% | -$168M |
|
|
SIOX
8
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $91.5M | 1.38% |
634,673
-10,222
| -2% | -$1.33M |
|
9
Zimmer Biomet
ZBH
$18.7B
| $89.8M | 1.35% |
901,320
+62,870
| +7% | +$6.15M |
|
10
Healthcare Realty
HR
$7.56B
| $83M | 1.25% |
3,077,854
-98,795
| -3% | -$2.55M |
|
11
CONMED
CNMD
$1.32B
| $79.6M | 1.2% |
1,807,015
-531,879
| -23% | -$23.1M |
|
12
Ultragenyx Pharmaceutical
RARE
$2.5B
| $70.7M | 1.06% |
629,934
-1,119
| -0.2% | -$112K |
|
|
ZLTQ
13
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $69.9M | 1.05% |
2,448,867
+1,194,581
| +95% | +$37.7M |
|
14
Prothena Corp
PRTA
$443M
| $66.7M | 1% |
978,900
+19,473
| +2% | +$1.17M |
|
15
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.8B
| $64.5M | 0.97% |
800,000
| – | – |
|
|
HZNP
16
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $64.2M | 0.96% |
2,960,933
+1,171,919
| +66% | +$22.8M |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $62.7M | 0.94% |
1,075,309
+172,361
| +19% | +$8.54M |
|
|
KYNB
18
Kyntra Bio
KYNB
$28.1M
| $61.9M | 0.93% |
81,277
+833
| +1% | +$553K |
|
|
CBPO
19
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $60.2M | 0.9% |
422,603
-93,791
| -18% | -$10.8M |
|
|
ITCI
20
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $54M | 0.81% |
1,003,313
+12,934
| +1% | +$652K |
|
21
Pfizer
PFE
$144B
| $53.6M | 0.8% |
1,749,129
+708,111
| +68% | +$22.3M |
|
22
Align Technology
ALGN
$12.8B
| $50.1M | 0.75% |
760,861
-608,173
| -44% | -$39M |
|
|
YHOO
23
DELISTED
Yahoo Inc
YHOO
| $47.7M | 0.72% |
1,434,428
+385,144
| +37% | +$12.9M |
|
24
Mohawk Industries
MHK
$6.96B
| $47.4M | 0.71% |
250,144
+13,426
| +6% | +$2.58M |
|
25
NextEra Energy
NEE
$186B
| $45.4M | 0.68% |
1,748,720
+903,784
| +107% | +$22.9M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, Visium Asset Management held 1,056 positions worth $6.66B, down 9.1% from $7.32B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Visium Asset Management withdrew a net $1.05B in Q4 2015, closing 479 positions and reducing 165 holdings. Its most notable exit was Bausch Health, an estimated $184M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 51% a quarter earlier, followed by Financials and Energy.
Against the trend, Visium Asset Management opened a new position in Elevance Health worth $43.4M.
- Visium Asset Management's largest Q4 2015 buy was Elevance Health: 311,300 shares worth $43.4M.
- Visium Asset Management added most to Brookdale Senior Living in Q4 2015, an estimated $95M increase.
- Visium Asset Management's biggest Q4 2015 reduction was Perrigo, cutting an estimated $168M.
- Visium Asset Management fully exited Bausch Health in Q4 2015, selling an estimated $184M.
- Visium Asset Management's ten largest holdings make up 27% of its $6.66B portfolio in Q4 2015.
- Visium Asset Management opened 179 new positions and closed 479 in Q4 2015.
- Visium Asset Management's portfolio value fell 9.1% quarter-over-quarter to $6.66B.
Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.